BFC Planning’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$85.8K Buy
418
+69
+20% +$13.7K ﹤0.01% 1301
2026
Q2
$65.4K Buy
349
+117
+50% +$17.1K ﹤0.01% 1421
2026
Q1
$22.6K Hold
232
– – ﹤0.01% 1657
2025
Q4
$18.5K Hold
232
– – ﹤0.01% 1786
2025
Q3
$10.8K Buy
232
+10
+5% +$392 ﹤0.01% 1881
2025
Q2
$8.17K Hold
222
– – ﹤0.01% 1896
2025
Q1
$7.85K Hold
222
– – ﹤0.01% 1865
2024
Q4
$9.7K Hold
222
– – ﹤0.01% 1779
2024
Q3
$10.1K Buy
+222
New +$9.7K ﹤0.01% 1750

Other funds holding RVMD

BFC Planning's RVMD Position: Q3 2026 in Review

BFC Planning increased its Revolution Medicines (RVMD) stake by 20% in Q3 2026, buying an estimated $13.7K and bringing the position to 418 shares worth $85.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1301.

BFC Planning first reported a position in RVMD in Q3 2024 and has held it in 9 quarters since. 590 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • BFC Planning held 418 shares of Revolution Medicines worth $85.8K as of Q3 2026.
  • BFC Planning bought 69 Revolution Medicines shares in Q3 2026, an estimated $13.7K.
  • Revolution Medicines made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1301 holding.
  • BFC Planning first reported a position in Revolution Medicines in Q3 2024 and has held it in 9 quarters since.
  • 590 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.